Penumbra
PEN
#1771
Rank
NZ$16.29 B
Marketcap
$424.67
Share price
-0.08%
Change (1 day)
3.18%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.40 Billion

According to Penumbra's latest financial reports the company's total debt is NZ$0.40 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.37 B-0.21%
2022-12-31NZ$0.37 B46.54%
2021-12-31NZ$0.25 B135.85%
2020-12-31NZ$0.10 B-11.93%
2019-12-31NZ$0.12 B
2018-12-31N/A
2013-12-31NZ$7.3 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$57.81 M-85.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.44 B 261.35%๐Ÿ‡บ๐Ÿ‡ธ USA